In this study, we demonstrated that pharmacological rescue of the TS-type p53 hotspot mutation R282W using ATO can lead to spontaneous tumor regression and significantly prolong the overall survival of mice, accompanying the activation of the immune response. This evidence concerns the gene TP53 and neoplasm.